62 Stocks Moving In Wednesday's Mid-Day Session

Comments
Loading...

Gainers

  • Constellation Pharmaceuticals, Inc. CNST shares jumped 156.7% to $37.91 after the company reported Q3 results.
  • comScore, Inc. SCOR climbed 24.9% to $3.11 following Q3 results.
  • Venator Materials PLC VNTR gained 24.4% to $3.6450 after the company reported better-than-expected Q3 EPS and sales results.
  • Provention Bio, Inc. PRVB climbed 22.5% to $8.42 after reporting Q3 results.
  • Inogen Inc INGN rose 21% to $71.75 after the company reported better-than-expected Q3 EPS and sales results. The company issued FY20 sales guidance above analyst estimates.
  • SunOpta Inc. STKL gained 20.8% to $2.4401 following Q3 results.
  • Boingo Wireless, Inc. WIFI climbed 19.8% to $11.62 after reporting Q3 results.
  • Computer Programs and Systems, Inc. CPSI shares gained 19.2% to $27.67 after reporting upbeat Q3 earnings.
  • Trupanion, Inc. TRUP shares rose 18.3% to $28.43 after the company posted upbeat Q3 results and reported a $15 million buyback program.
  • PaySign, Inc. PAYS gained 17.2% to $11.63 after the company reported better-than-expected Q3 EPS results.
  • Aquestive Therapeutics, Inc. AQST climbed 17.1% to $4.9528 following Q3 results.
  • Office Depot, Inc. ODP shares gained 17% to $2.5601 after the company reported better-than-expected Q3 EPS results. The company also reaffirmed FY19 sales guidance above analyst estimates.
  • Forty Seven, Inc. FTSV shares rose 16.5% to $7.93.
  • Aircastle Limited AYR climbed 16.4% to $32.11 after the company agreed to be acquired in a $2.4 billion deal.
  • Evolent Health, Inc. EVH gained 16% to $9.27 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 sales guidance above analyst estimates.
  • Kimball Electronics, Inc. KE climbed 15.2% to $17.67 following Q1 results.
  • Century Aluminum Company CENX gained 14.8% to $8.09 despite reporting weak Q3 results. BMO Capital maintained an Outperform rating on the company's stock and raised the price target from $7 to $9.
  • Agile Therapeutics, Inc. AGRX rose 14.7% to $2.7517 after climbing 34.83% on Tuesday.
  • Coty Inc. COTY gained 14.1% to $13.07 after the company reported better-than-expected Q1 EPS results.
  • LendingClub Corporation LC climbed 14% to $15.04 following Q3 results.
  • CymaBay Therapeutics, Inc. CBAY gained 13.6% to $5.89 following Q3 results.
  • MBIA Inc. MBI climbed 13.4% to $10.75 after reporting Q3 results.
  • NOW Inc. DNOW climbed 12.5% to $12.49 following upbeat Q3 earnings.
  • Stage Stores, Inc. SSI gained 12.3% to $2.93.
  • Purple Innovation, Inc. PRPL jumped 11.2% to $8.61 following strong Q3 results.
  • Paysign Inc PAYS rose 10.3% to $10.94 after the company reported better-than-expected Q3 EPS results.
  • HP Inc.. HPQ shares rose 9.6% to $20.17 following a report that Xerox is considering buying out HP.
  • Kratos Defense & Security Solutions, Inc. KTOS rose 5.7% to $18.97 after the company reported better-than-expected Q3 EPS results.
  • CVS Health Corporation. CVS shares rose 5% to $70.58 after the company reported upbeat earnings for its third quarter and raised its FY19 earnings guidance.


Check out these big penny stock gainers and losers

Losers

  • Fluidigm Corporation FLDM shares tumbled 51.2% to $2.4950 after the company reported worse-than-expected Q3 sales results.
  • Plantronics, Inc. PLT fell 40.6% to $23.42 after the company reported worse-than-expected Q2 EPS and sales results.
  • BlueLinx Holdings Inc. BXC dropped 39.6% to $18.72 following Q3 results.
  • Vapotherm, Inc. VAPO dipped 37.9% to $7.75 after the company posted downbeat Q3 sales and lowered FY19 sales guidance.
  • Supernus Pharmaceuticals, Inc. SUPN dropped 31.8% to $19.88 after the company reported downbeat Q3 results. The P301 trial of SPN-810 to treat impulsive aggression in attention deficit hyperactivity disorder in patients 6-11 did not meet the primary endpoint, according toSupernus Pharmaceuticals.
  • NextCure, Inc. NXTC dropped 28.1% to $66.31.
  • Neonode Inc. NEON fell 26.6% to $1.68 following Q3 results.
  • Town Sports International Holdings, Inc. CLUB dipped 23.6% to $1.59 following Q3 results.
  • ANI Pharmaceuticals, Inc. ANIP dipped 22.2% to $61.41 following Q3 results.
  • Radius Health, Inc. RDUS dropped 20.5% to $22.34 after reporting Q3 results.
  • Sierra Wireless, Inc. SWIR fell 20.3% to $8.99 after the company reported weaker-than-expected earnings for its third quarter and reported the purchase of M2M Group of companies in Australia.
  • Altice USA, Inc. ATUS fell 20% to $25.09 after the company reported worse-than-expected Q3 EPS and sales results.
  • Amneal Pharmaceuticals, Inc. AMRX dropped 19.9% to $2.7550 after the company reported worse-than-expected Q3 EPS and sales results.
  • Adesto Technologies Corporation IOTS dipped 19.3% to $7.51 following weak Q3 sales.
  • ArQule, Inc. ARQL dropped 18.5% to $7.93 after the company presented an abstract with early stage results of its reversible BTK inhibitor ARQ 531.
  • Camber Energy, Inc. CEI dropped 18.3% to $2.0998.
  • GW Pharmaceuticals plc GWPH shares fell 17.6% to $111.04 after the company reported Q3 earnings results.
  • HyreCar Inc. HYRE dropped 16.6% to $2.11 following Q3 results.
  • Vonage Holdings Corp. VG fell 16.6% to $8.39 after the company reported worse-than-expected Q3 EPS and sales results.
  • The Lovesac Company LOVE tumbled 16.6% to $14.12.
  • OptimizeRx Corporation OPRX fell 16.3% to $10.09 after the company reported worse-than-expected Q3 EPS and sales results.
  • WW International, Inc. WW fell 15.7% to $31.64 after the company reported worse-than-expected Q3 sales results.
  • Cornerstone Building Brands, Inc. CNR dropped 15.4% to $5.81 following downbeat quarterly sales.
  • KAR Auction Services, Inc. KAR dipped 15.3% to $21.59 after the company reported worse-than-expected Q3 EPS results. The company also issued FY19 EPS guidance below analyst estimates.
  • Diamondback Energy Inc FANG fell 15.2% to $76.57 after the company reported worse-than-expected Q3 sales results.
  • Acceleron Pharma Inc. XLRN dipped 14.5% to $40.74 following downbeat Q3 results.
  • Nu Skin Enterprises, Inc. NUS fell 14.4% to $39.69 after the company reported worse-than-expected Q3 sales results. The company also issued Q4 and FY19 EPS and sales guidance below analyst estimates.
  • The Hackett Group, Inc. HCKT dropped 13.1% to $15.29 after reporting weak Q3 results.
  • Red Robin Gourmet Burgers, Inc. RRGB shares fell 11.6% to $28.26 after the company reported worse-than-expected Q3 EPS results.
  • Perion Network Ltd. PERI shares fell 9.5% to $5.25 after the company reported Q3 results.
  • Intelsat S.A. I shares fell 9.1% to $23.93.
  • Acadia Healthcare Company Inc ACHC fell 5.3% to $29.72 after the company reported worse-than-expected Q3 EPS and sales results.
  • Match Group, Inc. MTCH fell 5.2% to $65.19 after the company reported Q3 earnings results.
Market News and Data brought to you by Benzinga APIs

Posted In: